[Corrigendum] Rab22a is a novel prognostic marker for cell progression in breast cancer

He,Miao; Shen,Leihua; Jiang,Chengwei; Gao,Ge; Wang,Keren; Jiao,Yan; Sun,Liang; Cui,Yingnan; Ke,Zirui; Yang,Zhaoying

doi:10.3892/ijmm.2021.4851

March-2021 Volume 47 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

March-2021 Volume 47 Issue 3

Full Size Image

Correction Open Access

[Corrigendum] Rab22a is a novel prognostic marker for cell progression in breast cancer

Authors:
- Miao He
- Leihua Shen
- Chengwei Jiang
- Ge Gao
- Keren Wang
- Yan Jiao
- Liang Sun
- Yingnan Cui
- Zirui Ke
- Zhaoying Yang
View Affiliations

Affiliations: Department of Anesthesia, The Second Hospital of Jilin University, Changchun, Jilin 130022, P.R. China, Department of General Surgery, Xi'an Central Hospital, Xi'an, Shanxi 710000, P.R. China, Department of Pathology, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, Department of Breast Surgery, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China
Published online on: January 11, 2021 https://doi.org/10.3892/ijmm.2021.4851
Article Number: 18
Copyright : © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Article

Int J Mol Med 45: [Related article:] 1037-1046, 2020; DOI: 10.3892/ijmm.2020.4486

Following the publication of this article, the authors have realized that Table I contained an error: The number of patients who were alive in the Rab22a high expression group should have been written as 77 instead of 772.

Table I

Clinicopathological characteristics of patient samples and expression of Rab22a in breast cancer.

A corrected version of the Table is shown on the next page (the corrected datum is highlighted in bold). The authors sincerely apologize for the error that was introduced during the preparation of this Table, and regret any inconvenience that this mistake has caused.

Table I

Clinicopathological characteristics of patient samples and expression of Rab22a in breast cancer.

Characteristics	Rab22a expression			P-value
Characteristics	Low	Middle	High	P-value
Age, years
<50	20	58	45
≥50	10	67	58	0.079
Menopause stage
No	20	68	55
Yes	10	57	48	0.415
Age at menarche, years
<15	19	71	39
≥15	11	54	64	0.005
Clinical stage
I	17	49	32
II	7	57	34
III	6	19	37	0.001
T classification
T1	22	80	53
T2	8	40	40
T3	0	5	9
T4	0	0	1	0.148
N classification
N0	19	71	47
N1	5	35	22
N2	2	13	13
N3	4	6	21	0.013
Nipple invasion
No	30	124	97
Yes	0	1	6	0.042
Venous invasion
No	23	90	60
Yes	7	35	43	0.044
Nerve invasion
No	26	99	82
Yes	4	26	21	0.640
Basal invasion
No	30	124	101
Yes	0	1	2	0.595
Pectoralis minor muscle invasion
No	30	124	101
Yes	0	1	2	0.595
Pathological differentiation
G1	4	10	7
G2	23	85	73
G3	3	30	23	0.446
ER status
Negative	5	32	33
Positive	25	93	70	0.216
PR status
Negative	6	41	40
Positive	24	84	63	0.151
Expression of Her-2
Negative	22	91	63
Positive	8	34	40	0.140
Expression of Ki67
Low expression	24	88	64
High expression	6	37	39	0.139
Molecular classification
Luminal A	15	48	24
Luminal B (Her-2-)	7	21	25
Luminal B (Her-2+)	3	25	23
Her-2+	3	13	16
Basal like	2	18	15	0.131
Vital status (at follow-up)
Alive	28	112	77
Dead	2	13	26	0.003

Characteristics	Rab22a expression			P-value
Characteristics	Low	Middle	High	P-value
Age, years
<50	20	58	45
≥50	10	67	58	0.079
Menopause stage
No	20	68	55
Yes	10	57	48	0.415
Age at menarche, years
<15	19	71	39
≥15	11	54	64	0.005
Clinical stage
I	17	49	32
II	7	57	34
III	6	19	37	0.001
T classification
T1	22	80	53
T2	8	40	40
T3	0	5	9
T4	0	0	1	0.148
N classification
N0	19	71	47
N1	5	35	22
N2	2	13	13
N3	4	6	21	0.013
Nipple invasion
No	30	124	97
Yes	0	1	6	0.042
Venous invasion
No	23	90	60
Yes	7	35	43	0.044
Nerve invasion
No	26	99	82
Yes	4	26	21	0.640
Basal invasion
No	30	124	101
Yes	0	1	2	0.595
Pectoralis minor muscle invasion
No	30	124	101
Yes	0	1	2	0.595
Pathological differentiation
G1	4	10	7
G2	23	85	73
G3	3	30	23	0.446
ER status
Negative	5	32	33
Positive	25	93	70	0.216
PR status
Negative	6	41	40
Positive	24	84	63	0.151
Expression of Her-2
Negative	22	91	63
Positive	8	34	40	0.140
Expression of Ki67
Low expression	24	88	64
High expression	6	37	39	0.139
Molecular classification
Luminal A	15	48	24
Luminal B (Her-2-)	7	21	25
Luminal B (Her-2+)	3	25	23
Her-2+	3	13	16
Basal like	2	18	15	0.131
Vital status (at follow-up)
Alive	28	112	77
Dead	2	13	26	0.003

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] Rab22a is a novel prognostic marker for cell progression in breast cancer

This article is mentioned in:

Article

Table I

Table I

Table I

Table I

Related Articles